Barclays PLC Takes $29,000 Position in Monogram Orthopaedics, Inc. (NASDAQ:MGRM)

Barclays PLC acquired a new position in shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 10,897 shares of the company’s stock, valued at approximately $29,000.

Separately, Geode Capital Management LLC raised its holdings in shares of Monogram Orthopaedics by 1,267.4% in the third quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after purchasing an additional 194,776 shares during the last quarter. 0.45% of the stock is owned by hedge funds and other institutional investors.

Monogram Orthopaedics Trading Up 1.4 %

NASDAQ:MGRM opened at $2.86 on Friday. The firm has a fifty day simple moving average of $2.43 and a 200 day simple moving average of $2.50. Monogram Orthopaedics, Inc. has a 1-year low of $1.53 and a 1-year high of $4.90. The stock has a market capitalization of $98.13 million, a PE ratio of -6.09 and a beta of 1.51.

Wall Street Analyst Weigh In

MGRM has been the subject of a number of analyst reports. Roth Mkm began coverage on shares of Monogram Orthopaedics in a research report on Monday, December 9th. They issued a “buy” rating and a $4.00 target price for the company. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a research report on Monday, December 9th.

Monogram Orthopaedics Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.